Status: current, Defined. Date: 31-Jan 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 956383011000036116 | gadoversetamide 4.96 g / 15 mL injection, 15 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 956385011000036115 | gadoversetamide 4.96 g/15 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| gadoversetamide 4.96 g/15 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| gadoversetamide 4.96 g/15 mL injection, vial | Is a | gadoversetamide | true | Inferred relationship | Some | ||
| gadoversetamide 4.96 g/15 mL injection, vial | has intended active ingredient | gadoversetamide | true | Inferred relationship | Some | 1935010900 | |
| gadoversetamide 4.96 g/15 mL injection, vial | has Australian BoSS | gadoversetamide | true | Inferred relationship | Some | 1935010900 | |
| gadoversetamide 4.96 g/15 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| gadoversetamide 4.96 g/15 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1935010901 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Optimark 4.96 g/15 mL injection, 15 mL vial | Is a | True | gadoversetamide 4.96 g/15 mL injection, vial | Inferred relationship | Some | |
| gadoversetamide 4.96 g/15 mL injection, 15 mL vial | has MPUU | True | gadoversetamide 4.96 g/15 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR